TY - JOUR
T1 - Peroxisome biogenesis deficiency attenuates the BDNF-TrkB pathway-mediated development of the cerebellum
AU - Abe, Yuichi
AU - Honsho, Masanori
AU - Itoh, Ryota
AU - Kawaguchi, Ryoko
AU - Fujitani, Masashi
AU - Fujiwara, Kazushirou
AU - Hirokane, Masaaki
AU - Matsuzaki, Takashi
AU - Nakayama, Keiko
AU - Ohgi, Ryohei
AU - Marutani, Toshihiro
AU - Nakayama, Keiichi I.
AU - Yamashita, Toshihide
AU - Fujiki, Yukio
N1 - Funding Information:
We thank R.J.A. Wanders for providing fibroblasts from a patient with PEX14 mutation. We also thank Y Nanri and S Okuno for technical assistance, K Shimizu for preparing the figures, and the other members of our laboratory for helpful discussion. We appreciate the technical assistance from The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences and Laboratory for Technical Support, Medical Institute of Bioregulation, Kyushu University. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research (no. JP17K15621 to Y Abe; nos. JP24247038, JP25112518, JP25116717, JP26116007, JP15K14511, JP15K21743, and JP17H03675 to Y Fujiki); grants from the Takeda Science Foundation (to Y Fujiki), the Naito Foundation (to Y Fujiki), the Japan Foundation for Applied Enzymology, and the Novartis Foundation (Japan) for the Promotion of Science (to Y Fujiki).
Publisher Copyright:
© 2018 Abe et al.
PY - 2018
Y1 - 2018
N2 - Peroxisome biogenesis disorders (PBDs) manifest as neurological deficits in the central nervous system, including neuronal migration defects and abnormal cerebellum development. However, the mechanisms underlying pathogenesis remain enigmatic. Here, to investigate how peroxisome deficiency causes neurological defects of PBDs, we established a new PBD model mouse defective in peroxisome assembly factor Pex14p, termed Pex14ΔC/ΔC mouse. Pex14ΔC/ΔC mouse manifests a severe symptom such as disorganization of cortical laminar structure and dies shortly after birth, although peroxisomal biogenesis and metabolism are partially defective. The Pex14ΔC/ΔC mouse also shows malformation of the cerebellum including the impaired dendritic development of Purkinje cells. Moreover, extracellular signal-regulated kinase and AKT signaling are attenuated in this mutant mouse by an elevated level of brain-derived neurotrophic factor (BDNF) together with the enhanced expression of TrkB-T1, a dominant-negative isoform of the BDNF receptor. Our results suggest that dysregulation of the BDNF-TrkB pathway, an essential signaling for cerebellar morphogenesis, gives rise to the pathogenesis of the cerebellum in PBDs.
AB - Peroxisome biogenesis disorders (PBDs) manifest as neurological deficits in the central nervous system, including neuronal migration defects and abnormal cerebellum development. However, the mechanisms underlying pathogenesis remain enigmatic. Here, to investigate how peroxisome deficiency causes neurological defects of PBDs, we established a new PBD model mouse defective in peroxisome assembly factor Pex14p, termed Pex14ΔC/ΔC mouse. Pex14ΔC/ΔC mouse manifests a severe symptom such as disorganization of cortical laminar structure and dies shortly after birth, although peroxisomal biogenesis and metabolism are partially defective. The Pex14ΔC/ΔC mouse also shows malformation of the cerebellum including the impaired dendritic development of Purkinje cells. Moreover, extracellular signal-regulated kinase and AKT signaling are attenuated in this mutant mouse by an elevated level of brain-derived neurotrophic factor (BDNF) together with the enhanced expression of TrkB-T1, a dominant-negative isoform of the BDNF receptor. Our results suggest that dysregulation of the BDNF-TrkB pathway, an essential signaling for cerebellar morphogenesis, gives rise to the pathogenesis of the cerebellum in PBDs.
UR - http://www.scopus.com/inward/record.url?scp=85057743785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057743785&partnerID=8YFLogxK
U2 - 10.26508/lsa.201800062
DO - 10.26508/lsa.201800062
M3 - Article
C2 - 30519675
AN - SCOPUS:85057743785
SN - 2575-1077
VL - 1
JO - Life Science Alliance
JF - Life Science Alliance
IS - 6
ER -